feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Business and Economy / Alaska Law Firm Deal Canceled Over Conflict Claims

Alaska Law Firm Deal Canceled Over Conflict Claims

14 Jan

•

Summary

  • Alaska terminated a contract with Baron & Budd over conflict-of-interest claims.
  • The lawsuit involves firefighting foam chemicals allegedly contaminating water.
  • This is the second time Alaska canceled a contract with a firm this year.
Alaska Law Firm Deal Canceled Over Conflict Claims

Alaska has once again terminated a contract with a national plaintiffs' law firm, Baron & Budd, due to alleged violations of conflict-of-interest provisions. The dispute arises from litigation targeting manufacturers of firefighting foam chemicals, identified as PFAS, which are linked to water contamination.

This decision follows a similar contract termination in October 2026 involving law firm Motley Rice, hired for opioid litigation, which Alaska also accused of violating confidentiality and conflict-of-interest rules. Baron & Budd, a Dallas-based firm, had been representing Alaska in its 2021 lawsuit concerning PFAS, a class of chemicals known for their persistence in the environment and links to health issues.

Baron & Budd stated they disagree with Alaska's assessment, arguing that lawyers routinely handle multiple clients in mass tort cases ethically. The firm highlighted its expertise in PFAS multi-district litigation, claiming it benefited Alaska. The state's lawsuit against manufacturers like 3M, DuPont, and Chemours is currently pending in federal court in Charleston, South Carolina.

trending

JPMorgan Chase earnings beat

trending

Patriots defeat Chargers 16-3

trending

Leafs beat Avalanche in OT

trending

Anthropic launches Claude for Healthcare

trending

Clippers beat Hornets

trending

Red Wings honor Fedorov

trending

Kings beat Los Angeles Lakers

trending

Emma Raducanu Hobart debut

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Alaska terminated the contract with Baron & Budd due to alleged violations of conflict-of-interest provisions in their PFAS firefighting foam litigation case.
Alaska is suing manufacturers of firefighting foam containing PFAS chemicals, alleging these substances contaminated water supplies.
Yes, in October 2026, Alaska also terminated a contract with Motley Rice over similar conflict-of-interest and confidentiality allegations.

Read more news on

Business and Economyside-arrow

You may also like

RedTape Founders Eye $510M Stake Sale to Global Investors

1 day ago • 7 reads

article image

India Inc Consolidates: Big Deals Reshape Sectors

11 Dec, 2025 • 160 reads

article image

Bank of America Boosts Eli Lilly: Obesity Drugs Drive Huge Upside

2 Dec, 2025 • 222 reads

article image

Coke Only: Mounjaro Patient's Christmas Meal Nightmare

3 Dec, 2025 • 187 reads

article image

Novo Nordisk Cuts Prices on Wegovy and Ozempic by 30% in the US

18 Nov, 2025 • 244 reads

article image